4.7 Article

Potential impact of family history-based screening guidelines on the detection of early-onset colorectal cancer

期刊

CANCER
卷 126, 期 13, 页码 3013-3020

出版社

WILEY
DOI: 10.1002/cncr.32851

关键词

case-control study; family history; guidelines; sensitivity; specificity; young-onset colorectal cancer

类别

资金

  1. National Cancer Institute (NCI) of the National Institutes of Health (NIH) [NCI/NIH 5R37CA222866]
  2. VA HSRD [5 I01 HX001574-04]
  3. Australasian Colorectal Cancer Family Registry [U01 CA074778, U01/U24 CA097735]
  4. Mayo Clinic Cooperative Family Registry for Colon Cancer Studies [U01/U24 CA074800]
  5. Ontario Familial Colorectal Cancer Registry [U01/U24 CA074783]
  6. Seattle Colorectal Cancer Family Registry [U01/U24 CA074794]
  7. University of Southern California Consortium Colorectal Cancer Family Registry [U01/U24 CA074799]
  8. University of Hawaii Colorectal Cancer Family Registry [U01/U24 CA074806, R01 CA104132]
  9. [U01CA167551]

向作者/读者索取更多资源

Background Initiating screening at an earlier age based on cancer family history is one of the primary recommended strategies for the prevention and detection of early-onset colorectal cancer (EOCRC), but data supporting the effectiveness of this approach are limited. The authors assessed the performance of family history-based guidelines for identifying individuals with EOCRC. Methods The authors conducted a population-based, case-control study of individuals aged 40 to 49 years with (2473 individuals) and without (772 individuals) incident CRC in the Colon Cancer Family Registry from 1998 through 2007. They estimated the sensitivity and specificity of family history-based criteria jointly recommended by the American Cancer Society, the US Multi-Society Task Force on CRC, and the American College of Radiology in 2008 for early screening, and the age at which each participant could have been recommended screening initiation if these criteria had been applied. Results Family history-based early screening criteria were met by approximately 25% of cases (614 of 2473 cases) and 10% of controls (74 of 772 controls), with a sensitivity of 25% and a specificity of 90% for identifying EOCRC cases aged 40 to 49 years. Among 614 individuals meeting early screening criteria, 98.4% could have been recommended screening initiation at an age younger than the observed age of diagnosis. Conclusions Of CRC cases aged 40 to 49 years, 1 in 4 met family history-based early screening criteria, and nearly all cases who met these criteria could have had CRC diagnosed earlier (or possibly even prevented) if earlier screening had been implemented as per family history-based guidelines. Additional strategies are needed to improve the detection and prevention of EOCRC for individuals not meeting family history criteria for early screening.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region

Kristina M. Jordahl, Anna Shcherbina, Andre E. Kim, Yu-Ru Su, Yi Lin, Jun Wang, Conghui Qu, Demetrius Albanes, Volker Arndt, James W. Baurley, Sonja I. Berndt, Stephanie A. Bien, D. Timothy Bishop, Emmanouil Bouras, Hermann Brenner, Daniel D. Buchanan, Arif Budiarto, Peter T. Campbell, Robert Carreras-Torres, Graham Casey, Tjeng Wawan Cenggoro, Andrew Chan, David Conti, Christopher H. Dampier, Matthew A. Devall, Virginia Diez-Obrero, Niki Dimou, David A. Drew, Jane C. Figueiredo, Steven Gallinger, Graham G. Giles, Stephen B. Gruber, Andrea Gsur, Marc J. Gunter, Heather Hampel, Sophia Harlid, Tabitha A. Harrison, Akihisa Hidaka, Michael Hoffmeister, Jeroen R. Huyghe, Mark A. Jenkins, Amit Joshi, Temitope Keku, Susanna C. Larsson, Loic Le Marchand, Juan Pablo Lewinger, Li Li, Bharuno Mahesworo, Victor Moreno, John L. Morrison, Neil Murphy, Hongmei Nan, Rami Nassir, Polly A. Newcomb, Mireia Obon-Santacana, Shuji Ogino, Jennifer Ose, Rish K. Pai, Julie R. Palmer, Nikos Papadimitriou, Bens Pardamean, Anita R. Peoples, Paul D. P. Pharoah, Elizabeth A. Platz, John Potter, Ross L. Prentice, Gad Rennert, Edward Ruiz-Narvaez, Lori C. Sakoda, Peter C. Scacheri, Stephanie L. Schmit, Robert E. Schoer, Martha L. Slattery, Mariana C. Stern, Catherine M. Tangen, Stephen N. Thibodeau, Duncan C. Thomas, Yu Tian, Konstantinos K. Tsilidis, Cornelia M. Ulrich, Franzel J. B. van Duijnhoven, Bethany Van Guelpen, Kala Visvanathan, Pavel Vodicka, Emily White, Alicja Wolk, Michael O. Woods, Anna H. Wu, Natalia Zemlianskaia, Jenny Chang-Claude, W. James Gauderman, Li Hsu, Anshul Kundaje, Ulrike Peters

Summary: This study reveals that the association between colorectal cancer and the 10q24.2/COX15 gene region is strongest in nondrinkers. The rs1318920 variant is identified as the putative causal regulatory variant for this region, suggesting a possible multifaceted functional effect.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Editorial Material Gastroenterology & Hepatology

Polygenic Risk Scores for Follow Up After Colonoscopy and Polypectomy: Another Tool for Risk Stratification and Planning Surveillance?

Samir Gupta, Aaron P. Thrift

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy

Samir Gupta, Ashley Earles, Ranier Bustamante, Olga V. Patterson, Andrew J. Gawron, Tonya R. Kaltenbach, Hanin Yassin, Mark Lamm, Shailja C. Shah, Sameer Dev Saini, Deborah A. Fisher, Maria Elena Martinez, Karen Messer, Joshua Demb, Lin Liu

Summary: In this study, the colonoscopist's adenoma detection rate (ADR) was found to be independently associated with the risk of moderate-to-high complexity adenomas. Compared to the highest quintile (ADR >47.0%), the risk of moderate-to-high complexity adenomas increased by 1.48- to 1.66-fold in the lowest 3 quintiles (ADR <19.7%-39.3%).

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Baseline Characteristics and Longitudinal Outcomes of Traditional Serrated Adenomas: A Cohort Study

Mehul Trivedi, Suha Godil, Joshua Demb, Ashley Earles, Ranier Bustamante, Olga Patterson, Andrew J. Gawron, Tonya Kaltenbach, Sumana Mahata, Lin Liu, Samir Gupta

Summary: This study aimed to investigate the clinical characteristics and long-term outcomes associated with traditional serrated adenomas (TSAs). The results showed that TSA patients have an increased risk for colorectal cancer (CRC) and a risk of developing other high-risk neoplasia during follow-up surveillance colonoscopy.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Development and Validation of a National US Achalasia Cohort: The Veterans Affairs Achalasia Cohort (VA-AC)

Eric E. Low, Rena Yadlapati, Lin Liu, Ranier Bustamante, Samir Gupta

Summary: The study team established a large cohort of individuals with achalasia within the Veterans Health Administration (VHA), allowing for further investigation of risk factors and outcomes of this esophageal motility disorder.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Oncology

DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer

Huichuan Yu, Xiaolin Wang, Liangliang Bai, Guannan Tang, Kelly T. Carter, Ji Cui, Pinzhu Huang, Li Liang, Yanqing Ding, Muyan Cai, Meijin Huang, Huanliang Liu, Guangwen Cao, Steven Gallinger, Rish K. Pai, Daniel D. Buchanan, Aung Ko Win, Polly A. Newcomb, Jianping Wang, William M. Grady, Yanxin Luo

Summary: This study demonstrated the prognostic significance of DNA methylation in early-stage colorectal cancer patients, with MePEC identifying an epigenetic subtype at high risk of recurrence and improving the prognostic accuracy of current clinical variables.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Medicine, Research & Experimental

Contingency management and pre-exposure prophylaxis adherence support services (CoMPASS): A hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs

Minhee L. Sung, Adam Viera, Denise Esserman, Guangyu Tong, Daniel Davidson, Sherry Aiudi, Genie L. Bailey, Ashley L. Buchanan, Marianne Buchelli, Mark Jenkins, Betsey John, Jennifer Kolakowski, Albana Lame, Sean M. Murphy, Elizabeth Porter, Laura Simone, Manuel Paris, Carla J. Rash, E. Jennifer Edelman

Summary: This study introduces a new research called CoMPASS, which aims to promote HIV risk reduction among persons who inject drugs (PWID). It is a hybrid type 1 effectiveness-implementation trial that utilizes rewards and ongoing support to encourage PWID to use HIV preexposure prophylaxis (PrEP). Trained PrEP navigators deliver interventions, including PrEP and other relevant treatments. The primary outcome is sustained PrEP adherence at 24 weeks. The results of this study will provide insights into the feasibility and impact of implementing CoMPASS in community-based organizations.

CONTEMPORARY CLINICAL TRIALS (2023)

Article Gastroenterology & Hepatology

Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases

Tomotaka Ugai, Naohiko Akimoto, Koichiro Haruki, Tabitha A. Harrison, Yin Cao, Conghui Qu, Andrew T. Chan, Peter T. Campbell, Sonja Berndt, Daniel D. Buchanan, Amanda J. Cross, Brenda Diergaarde, Steven J. Gallinger, Marc J. Gunter, Sophia Harlid, Akihisa Hidaka, Michael Hoffmeister, Hermann Brenner, Jenny Chang-Claude, Li Hsu, Mark A. Jenkins, Yi Lin, Roger L. Milne, Victor Moreno, Polly A. Newcomb, Reiko Nishihara, Mireia Obon-Santacana, Rish K. Pai, Lori C. Sakoda, Robert E. Schoen, Martha L. Slattery, Wei Sun, Efrat L. Amitay, Elizabeth Alwers, Stephen N. Thibodeau, Amanda E. Toland, Bethany Van Guelpen, Syed H. Zaidi, John D. Potter, Jeffrey A. Meyerhardt, Marios Giannakis, Mingyang Song, Jonathan A. Nowak, Ulrike Peters, Amanda Phipps, Shuji Ogino

Summary: This study analyzed 13,101 colorectal cancer cases and found a significant association between tumor location and molecular features. The detailed colonic location and tumor molecular features play an important role in the prognostication and precision medicine of colon cancer.

JOURNAL OF GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Risk of Incident and Fatal Colorectal Cancer After Young-Onset Adenoma Diagnosis: A National Cohort Study

Yas Casey, Joshua Demb, Ngozi Enwerem, Lin Liu, Christian Jackson, Ashley Earles, Ranier Bustamante, Sumana Mahata, Shailja Shah, Samir Gupta

Summary: Young-onset advanced adenoma diagnosis is associated with an 8-fold increased risk of incident colorectal cancer compared with normal colonoscopy. However, the cumulative incidence and mortality of colorectal cancer at 10 years among individuals with either young onset non-advanced or advanced adenoma diagnosis were both relatively low.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Development and Validation of the Veterans Affairs Eosinophilic Esophagitis Cohort

Eric E. Low, Qingyuan Song, Rena Yadlapati, Evan S. Dellon, Seema Aceves, Lin Liu, Samir Gupta, Yash A. Choksi, Shailja C. Shah

Summary: Researchers developed and validated two highly accurate coding algorithms for EoE, establishing a nationwide VHA cohort for adults with EoE for future studies.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Colorectal Cancer Risk Assessment and Precision Approaches to Screening: Brave New World or Worlds Apart?

Fay Kastrinos, Sonia S. Kupfer, Samir Gupta

Summary: Current colorectal cancer (CRC) screening recommendations are based on age, but precision screening using additional factors could improve outcomes and resource utilization. Prediction models can identify high-risk groups for more intensive screening and low-risk groups for less invasive screening. Developing reliable and accurate prediction models and studying their feasibility and cost-effectiveness are critical for future implementation of precision CRC screening.

GASTROENTEROLOGY (2023)

Review Genetics & Heredity

Update of penetrance estimates in Birt-Hogg-Dube syndrome

Fiona Jane Bruinsma, James G. Dowty, Aung Ko Win, Laura C. Goddard, Prachi Agrawal, Domenico Attina', Nabil Bissada, Monica De Luise, Daniel B. Eisen, Mitsuko Furuya, Giuseppe Gasparre, Maurizio Genuardi, Anne-Marie Gerdes, Thomas Van Overeem Hansen, Arjan C. Houweling, Paul Christiaan Johannesma, Andre Lencastre, Derek Lim, Noralane M. Lindor, Valentina Luzzi, Maeve Lynch, Antonella Maffe, Fred H. Menko, Guido Michels, Jose S. Pulido, Ryu H. Jay, Elke C. Sattler, Ortrud K. Steinlein, Sara Tomassetti, Kathy Tucker, Daniela Turchetti, Irma van de Beek, Lore van Riel, Maurice van Steensel, Thierry Zenone, Maurizo Zompatori, Jennifer Walsh, Davide Bondavalli, Eamonn R. Maher, Ingrid M. Winship

Summary: BHD syndrome is a rare genetic syndrome caused by FLCN gene variants, which can increase the risk of various manifestations including fibrofolliculomas, pulmonary cysts, pneumothorax, and renal cell carcinoma. This study provides updated penetrance estimates based on a large dataset, which are crucial for the genetic counseling and clinical management of BHD syndrome.

JOURNAL OF MEDICAL GENETICS (2023)

Correction Genetics & Heredity

Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (vol 55, pg 89, 2023)

Ceres Fernandez-Rozadilla, Maria Timofeeva, Zhishan Chen, Philip Law, Minta Thomas, Stephanie Schmit, Virginia Diez-Obrero, Li Hsu, Juan Fernandez-Tajes, Claire Palles, Kitty Sherwood, Sarah Briggs, Victoria Svinti, Kevin Donnelly, Susan Farrington, James Blackmur, Peter Vaughan-Shaw, Xiao-ou Shu, Jirong Long, Qiuyin Cai, Xingyi Guo, Yingchang Lu, Peter Broderick, James Studd, Jeroen Huyghe, Tabitha Harrison, David Conti, Christopher Dampier, Mathew Devall, Fredrick Schumacher, Marilena Melas, Gad Rennert, Mireia Obon-Santacana, Vicente Martin-Sanchez, Ferran Moratalla-Navarro, Jae Hwan Oh, Jeongseon Kim, Sun Ha Jee, Keum Ji Jung, Sun-Seog Kweon, Min-Ho Shin, Aesun Shin, Yoon-Ok Ahn, Dong-Hyun Kim, Isao Oze, Wanqing Wen, Keitaro Matsuo, Koichi Matsuda, Chizu Tanikawa, Zefang Ren, Yu-Tang Gao, Wei-Hua Jia, John Hopper, Mark Jenkins, Aung Ko Win, Rish Pai, Jane Figueiredo, Robert Haile, Steven Gallinger, Michael Woods, Polly Newcomb, David Duggan, Jeremy Cheadle, Richard Kaplan, Timothy Maughan, Rachel Kerr, David Kerr, Iva Kirac, Jan Bohm, Lukka-Pekka Mecklin, Pekka Jousilahti, Paul Knekt, Lauri Aaltonen, Harri Rissanen, Eero Pukkala, Johan Eriksson, Tatiana Cajuso, Ulrika Hanninen, Johanna Kondelin, Kimmo Palin, Tomas Tanskanen, Laura Renkonen-Sinisalo, Brent Zanke, Satu Mannisto, Demetrius Albanes, Stephanie Weinstein, Edward Ruiz-Narvaez, Julie Palmer, Daniel Buchanan, Elizabeth Platz, Kala Visvanathan, Cornelia Ulrich, Erin Siegel, Stefanie Brezina, Andrea Gsur, Peter Campbell, Jenny Chang-Claude, Michael Hoffmeister, Hermann Brenner, Martha Slattery, John Potter, Konstantinos Tsilidis, Matthias Schulze, Marc Gunter, Neil Murphy, Antoni Castells, Sergi Castellvi-Bel, Leticia Moreira, Volker Arndt, Anna Shcherbina, Mariana Stern, Bens Pardamean, Timothy Bishop, Graham Giles, Melissa Southey, Gregory Idos, Kevin McDonnell, Zomoroda Abu-Ful, Joel Greenson, Katerina Shulman, Flavio Lejbkowicz, Kenneth Offit, Yu-Ru Su, Robert Steinfelder, Temitope Keku, Bethany van Guelpen, Thomas Hudson, Heather Hampel, Rachel Pearlman, Sonja Berndt, Richard Hayes, Marie Elena Martinez, Sushma Thomas, Douglas Corley, Paul Pharoah, Susanna Larsson, Yun Yen, Heinz-Josef Lenz, Emily White, Li Li, Kimberly Doheny, Elizabeth Pugh, Tameka Shelford, Andrew Chan, Marcia Cruz-Correa, Annika Lindblom, David Hunter, Amit Joshi, Clemens Schafmayer, Peter Scacheri, Anshul Kundaje, Deborah Nickerson, Robert Schoen, Jochen Hampe, Zsofia Stadler, Pavel Vodicka, Ludmila Vodickova, Veronika Vymetalkova, Nickolas Papadopoulos, Chistopher Edlund, William Gauderman, Duncan Thomas, David Shibata, Amanda Toland, Sanford Markowitz, Andre Kim, Stephen Chanock, Franzel van Duijnhoven, Edith Feskens, Lori Sakoda, Manuela Gago-Dominguez, Alicja Wolk, Alessio Naccarati, Barbara Pardini, Liesel FitzGerald, Soo Chin Lee, Shuji Ogino, Stephanie Bien, Charles Kooperberg, Christopher Li, Yi Lin, Ross Prentice, Conghui Qu, Stephane Bezieau, Catherine Tangen, Elaine Mardis, Taiki Yamaji, Norie Sawada, Motoki Iwasaki, Christopher Haiman, Loic Le Marchand, Anna Wu, Chenxu Qu, Caroline McNeil, Gerhard Coetzee, Caroline Hayward, Ian Deary, Sarah Harris, Evropi Theodoratou, Stuart Reid, Marion Walker, Li Yin Ooi, Victor Moreno, Graham Casey, Stephen Gruber, Ian Tomlinson, Wei Zheng, Malcolm Dunlop, Richard Houlston, Ulrike Peters

NATURE GENETICS (2023)

Article Oncology

Using DEPendency of Association on the Number of Top Hits (DEPTH) as a Complementary Tool to Identify Novel Colorectal Cancer Loci

John Lai, Chi Kuen Wong, Daniel F. Schmidt, Miroslaw K. Kapuscinski, Karen Alpen, Robert J. Macinnis, Daniel D. Buchanan, Aung K. Win, Jane C. Figueiredo, Andrew T. Chan, Tabitha A. Harrison, Michael Hoffmeister, Emily White, Loic Le Marchand, Rish K. Pai, Ulrike Peters, John L. Hopper, Mark A. Jenkins, Enes Makalic

Summary: The DEPTH analysis method can be used to identify candidate susceptibility regions for colorectal cancer, and it has identified regions that conventional analyses cannot detect in larger datasets. DEPTH identified many new candidate susceptibility regions in the CCFR and GECCO studies, and it found four reproducible regions.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

Meeting Abstract Oncology

SMARTscreen: Using a novel SMS with narrative communication to increase uptake of the National Bowel Cancer Screening Program

Jennifer G. McIntosh, Jon Emery, Anna Wood, Patty Chondros, Tina Campbell, Edweana Wenkart, Ian Dixon, Julie Toner, Javiera Martinez Gutierrez, Linda Govan, Gemma Buckle, Mark Jenkins

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2022)

暂无数据